Form 10-Q PROCYON CORP For: Dec 31
Tweet
Share
E-mail
UNITED STATES SECURITIES & EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
| | QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For Quarterly Period Ended |
or
| | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to |
Commission File Number:
PROCYON CORPORATION
(Exact Name of Registrant as specified in its charter)
| (State of Incorporation) | (I.R.S. Employer Identification Number) |
(Address of Principal Executive Offices)
(
(Registrant’s Telephone Number, Including Area Code)
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
| None | None | None |
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and “emerging growth company” in Rule 12b-2 of the Exchange Act.
| Large accelerated filer ☐ | Accelerated filer ☐ |
| Smaller reporting company | |
| Emerging growth company |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes
Indicate the number of shares outstanding of each of the issuer's classes of common stock, as of the latest practicable date: Common stock, no par value;
| Item | Page |
| PART I. - FINANCIAL INFORMATION | |
| ITEM 1. FINANCIAL STATEMENTS |
3 |
| Index to Financial Statements |
|
| Financial Statements: | |
| Consolidated Balance Sheets |
3 |
| Consolidated Statements of Operations |
4 |
| Consolidated Statements of Changes in Stockholders’ Equity |
5 |
| Consolidated Statements of Cash Flows |
6 |
| Notes to Consolidated Financial Statements |
7 |
| ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS |
13 |
| ITEM 4. CONTROLS AND PROCEDURES |
17 |
| PART II. - OTHER INFORMATION |
|
| ITEM 5. OTHER INFORMATION |
17 |
| ITEM 6. EXHIBITS |
18 |
| SIGNATURES |
19 |
PROCYON CORPORATION & SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
December 31, 2021 and June 30, 2021
| (unaudited) | (audited) | |||||||
|
| December 31, | June 30, | ||||||
| 2021 | 2021 | |||||||
| ASSETS | ||||||||
| CURRENT ASSETS | ||||||||
| Cash | $ | $ | ||||||
| Certificates of Deposit, plus accrued interest | ||||||||
| Accounts Receivable, less allowance for doubtful accounts of $ and $, respectively. | ||||||||
| Inventories | ||||||||
| Prepaid Expenses | ||||||||
| TOTAL CURRENT ASSETS | ||||||||
| PROPERTY AND EQUIPMENT, NET | ||||||||
| OTHER ASSETS | ||||||||
| Deposits | ||||||||
| Inventories | ||||||||
| Intangible Asset | ||||||||
| ROU Assets - Operating Leases | ||||||||
| Deferred Tax Asset, net valuation allowance of $ and $, respectively. | ||||||||
| TOTAL ASSETS | $ | $ | ||||||
| LIABILITIES AND STOCKHOLDERS' EQUITY | ||||||||
| CURRENT LIABILITIES | ||||||||
| Accounts Payable | $ | $ | ||||||
| Lease Liability, Current | ||||||||
| Accrued Expenses | ||||||||
| TOTAL CURRENT LIABILITIES | ||||||||
| LONG TERM LIABILITIES | ||||||||
| Lease Liability - Operating Leases | ||||||||
| TOTAL LONG TERM LIABILITIES | ||||||||
| TOTAL LIABILITIES | ||||||||
| COMMITMENTS AND CONTINGENCIES (NOTE I) | ||||||||
| STOCKHOLDERS' EQUITY | ||||||||
| Preferred Stock, shares authorized, issued. | - | - | ||||||
| Series A Cumulative Convertible Preferred Stock, par value; shares authorized; shares issued and outstanding. | ||||||||
| Common Stock, par value, shares authorized; shares issued and outstanding. | ||||||||
| Paid-in Capital | ||||||||
| Accumulated Deficit | ( | ) | ( | ) | ||||
| TOTAL STOCKHOLDERS' EQUITY | ||||||||
| TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY | $ | $ | ||||||
The accompanying notes are an integral part of these financial statements.
PROCYON CORPORATION & SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS
Three and Six Months Ended December 31, 2021 and 2020
| (unaudited) | (unaudited) | (unaudited) | (unaudited) | |||||||||||||
| Three Months | Three Months | Six Months | Six Months | |||||||||||||
| Ended | Ended | Ended | Ended | |||||||||||||
| Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2021 | Dec. 31, 2020 | |||||||||||||
| NET SALES | $ | $ | $ | $ | ||||||||||||
| COST OF SALES | ||||||||||||||||
| GROSS PROFIT | ||||||||||||||||
| OPERATING EXPENSES | ||||||||||||||||
| Salaries and Benefits | ||||||||||||||||
| Selling, General and Administrative | ||||||||||||||||
| INCOME / (LOSS) FROM OPERATIONS | ( | ) | ||||||||||||||
| OTHER INCOME (EXPENSE) | ||||||||||||||||
| Interest Income / (Expense) | ( | ) | ( | ) | ||||||||||||
| ( | ) | ( | ) | |||||||||||||
| INCOME / (LOSS) BEFORE INCOME TAXES | ( | ) | ||||||||||||||
| INCOME TAX (EXPENSE) / BENEFIT | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||
| NET INCOME / (LOSS) | ( | ) | ( | ) | ||||||||||||
| Dividend requirements on preferred stock | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||
| Basic net income (loss) available to common shares | $ | ( | ) | $ | $ | ( | ) | $ | ||||||||
| Basic net income (loss) per common share | $ | ( | ) | $ | $ | ( | ) | $ | ||||||||
| Weighted average number of common shares outstanding | ||||||||||||||||
| Diluted net income (loss) per common share | $ | ( | ) | $ | $ | ( | ) | $ | ||||||||
| Weighted average number of common shares outstanding, diluted | ||||||||||||||||
The accompanying notes are an integral part of these financial statements.
PROCYON CORPORATION & SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY
For the Six Months Ended December 31, 2021 and 2020
| Six Months Ended December 31, 2021 | Preferred Stock | Common Stock | Paid-In | Accumulated | Total Stockholders' | |||||||||||||||||||||||
| Shares | Amount | Shares | Amount | Capital | Deficit | Equtiy | ||||||||||||||||||||||
| Balance, June 30, 2021 | $ | $ | $ | $ | ( | ) | $ | |||||||||||||||||||||
| Net Income | - | - | ||||||||||||||||||||||||||
| Balance, September 30, 2021 | ( | ) | $ | |||||||||||||||||||||||||
| Net Income (Loss) | - | - | ( | ) | ( | ) | ||||||||||||||||||||||
| Balance, December 31, 2021 | $ | $ | $ | $ | ( | ) | $ | |||||||||||||||||||||
| Six Months Ended December 31, 2020 |
Preferred Stock |
Common Stock | Paid-In |
Accumulated |
Total Stockholders' |
|||||||||||||||||||||||
| Shares |
Amount |
Shares |
Amount |
Capital |
Deficit |
Equtiy |
||||||||||||||||||||||
| Balance, June 30, 2020 |
$ | $ | $ | $ | ( |
) | $ | |||||||||||||||||||||
| Net Income |
- | - | ||||||||||||||||||||||||||
| Balance, September 30, 2020 |
$ | $ | $ | $ | ( |
) | $ | |||||||||||||||||||||
| Net Income (Loss) |
- | - | ||||||||||||||||||||||||||
| Balance, December 31, 2020 |
$ | $ | $ | $ | ( |
) | $ | |||||||||||||||||||||
The accompanying notes are an integral part of these financial statements.
PROCYON CORPORATION & SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
For the Six Months Ending December 31, 2021 and 2020
| (unaudited) December 31, 2021 |
(unaudited) December 31, 2020 |
|||||||
| CASH FLOWS FROM OPERATING ACTIVITIES |
||||||||
| Net (Loss) / Income |
$ | ( |
) | $ | ||||
| Adjustments to reconcile net income to net cash (used in) / provided by operating activities: |
||||||||
| Depreciation |
||||||||
| Right of Use Asset Amortization |
||||||||
| Deferred Income Taxes |
||||||||
| Valuation Allowance |
( |
) | ||||||
| Accrued Interest on Certificates of Deposit | ( |
) | ( |
) | ||||
| Decrease (increase) in: | ||||||||
| Accounts Receivable |
( |
) | ||||||
| Deposits |
( |
) | ‐ |
|||||
| Inventory |
( |
) | ( |
) | ||||
| Prepaid Expenses |
( |
) | ||||||
| Increase (decrease) in: | ||||||||
| Accounts Payable |
( |
) | ( |
) | ||||
| Accrued Expenses |
( |
) | ( |
) | ||||
| NET CASH (USED IN) OPERATING ACTIVITIES |
( |
) | ( |
) | ||||
| CASH FLOW FROM INVESTING ACTIVITIES |
||||||||
| Purchase of property & equipment |
( |
) | ( |
) | ||||
| NET CASH (USED IN) INVESTING ACTIVITIES |
( |
) | ( |
) | ||||
| CASH FLOW FROM FINANCING ACTIVITIES |
||||||||
| Purchase of CD |
‐ |
‐ |
||||||
| Increase in Operating Lease Liability | ( |
) | ||||||
| NET CASH PROVIDED BY / (USED IN) FINANCING ACTIVITIES |
( |
) | ||||||
| NET CHANGE IN CASH |
( |
) | ( |
) | ||||
| CASH AT BEGINNING OF PERIOD |
||||||||
| CASH AT END OF PERIOD |
$ | $ | ||||||
| SUPPLEMENTAL DISCLOSURES |
||||||||
| Interest Paid |
$ | $ | ||||||
| Taxes Paid | $ | $ | ||||||
NONCASH DISCLOSURE
During the six months ended December 31, 2019, we established a Right of Use Asset in the amount of $
During the quarter ended September 30, 2020, we increased a Right of Use Asset and corresponding lease liability in the amount of $
The accompanying notes are an integral part of these financial statements.
Notes to Financial Statements
NOTE A - SUMMARY OF ACCOUNTING POLICIES
The interim consolidated financial statements included herein have been prepared by the Company without audit, pursuant to the rules and regulations of the Securities and Exchange Commission. Certain information and footnote disclosures normally included in the financial statements prepared in accordance with generally accepted accounting principles ("GAAP") have been condensed or omitted as allowed by such rules and regulations. The Company believes that the disclosures are adequate to make the information presented not misleading. These consolidated financial statements should be read in conjunction with the Company's audited consolidated financial statements dated June 30, 2021, and as contained in the Company's annual report on Form 10-K, as filed with the Securities and Exchange Commission on October 8, 2021 and amended on Form 10-K/A, as filed with the Securities and Exchange Commission on November 12, 2021, which contain certain restatements to the June 30, 2021 financial statements. The results for interim periods are not necessarily indicative of results that may be expected for any other interim period or for the full year.
Management of the Company has prepared the accompanying unaudited condensed consolidated financial statements prepared in conformity with generally accepted accounting principles, which require the use of management estimates, contain all adjustments (including normal recurring adjustments) necessary to present fairly the operations and cash flows for the period presented and to make the financial statements not misleading.
STOCK-BASED COMPENSATION
Stock based compensation is accounted for in accordance with Topic 718 - Compensation - Stock Compensation in the Accounting Standards Codification. Pursuant to Topic 718, all share-based payments to employees, including grants of employee stock options, are to be recognized in the statement of operations based upon their fair values. Topic 718 rescinds the acceptance of pro forma disclosure. In December 2009, our shareholders approved the adoption of a new stock option plan, providing the Company a continued means of offering stock-based compensation.
On December 31, 2021, there were
The fair value of a stock option is determined using the Black-Scholes option-pricing model, which values options based on the stock price at the grant date, the expected life of the option, the estimated volatility of the stock, the expected dividend payments, and the risk-free interest rate over the life of the option. There were
The Black-Scholes option valuation model was developed for estimating the fair value of traded options that have no vesting restrictions and are fully transferable. Because option valuation models require the use of subjective assumptions, changes in these assumptions can materially affect the fair value of the options. Our options do not have the characteristics of traded options, therefore, the option valuation models do not necessarily provide a reliable measure of the fair value of our options.
EARNINGS PER SHARE
Basic earnings per share (EPS) is computed by dividing income available to common stockholders by the weighted-average number of common shares outstanding for the period. Diluted EPS reflects the potential dilution that would occur if dilutive securities such as stock options and other contracts to issue Common Stock were exercised or converted into Common Stock or resulted in the issuance of Common Stock that then shared in earnings. We use the treasury stock method to compute potential common shares from stock options and the as-if-converted method to compute potential common shares from Preferred Stock.
For the three and six months ended December 31, 2021, the potential dilutive effects of the preferred stock and stock options were included in the weighted-average shares outstanding.
NOTE B - INVENTORIES
| December 31, 2021 |
June 30,
2021
| |||||||
| Finished Goods | $ | $ | ||||||
| Raw Materials | ||||||||
| $ | $ | |||||||
Holders of the Preferred Stock have the right to convert their shares of Preferred Stock into an equal number of shares of Common Stock of the Company. In addition, Preferred Stock holders have the right to vote the number of shares into which their shares are convertible into Common Stock. Such preferred shares will automatically convert into share of Common Stock at the close of a public offering of Common Stock by the Company provided the Company receives gross proceeds of at least $
NOTE D - INCOME TAXES AND AVAILABLE CARRYFORWARD
|
Six Months
12/31/2021
| Six Months 12/31/2020 | |||||||
| Current | ||||||||
| Federal | $ | $ | ||||||
| State | ||||||||
| $ | $ | |||||||
| Deferred | ||||||||
| Federal | $ | ( | ) | $ | ( | ) | ||
| State | ( | ) | ( | ) | ||||
| $ | ( | ) | $ | ( | ) | |||
| Total Income Tax Benefit / (Expense) | $ | ( | ) | $ | ( | ) | ||
Deferred income taxes reflect the net tax effects of the temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Significant components of the Company's deferred tax assets and liabilities are as follows:
| Non-Current | ||||
| Deferred tax assets | ||||
| NOL and contribution carryforwards | $ | |||
| Share based payments | ||||
| Lease liabilities - operating leases | ||||
| Accrued compensated absences | ||||
| Accrued bonus | ||||
| Allowance for doubtful accounts | ||||
| Total deferred tax assets | ||||
| Deferred tax (liabilities) | ||||
| Right-of-use-assets - operating leases | ( | ) | ||
| Excess of tax over book depreciation | ( | ) | ||
| Total deferred tax (liabilities) | ( | ) | ||
| Total deferred tax asset | ||||
| Valuation Allowance | ( | ) | ||
| Net Deferred Tax Asset | $ | |||
| The change in the valuation allowance is as follows: | ||||
| June 30, 2021 | $ | |||
| December 31, 2021 | $ | ( | ) | |
| $ | ( | ) | ||
Income taxes for the six months ended December 31, 2021 and 2020 differ from the amounts computed by applying the effective income tax rate of
| Six Months Decemember 31, 2021 | Six Months December 31, 2020 | |||||||
| Expected (provision) at US statutory rate | $ | ( | ) | $ | ( | ) | ||
| State income tax net of federal (provision) | ( | ) | ( | ) | ||||
| Nondeductible Expense | ( | ) | ( | ) | ||||
| Change in estimates of loss carryforward | ( | ) | ( | ) | ||||
| Change in valuation allowance | ( | ) | $ | |||||
| Income Tax (Expense) | $ | ( | ) | $ | ( | ) | ||
| ROU assets - operating leases obtained in exchange for lease liabilities - operating leases | $ | |||
| Amortization of ROU assets since lease inception | $ | ( | ) | |
| ROU assets - operating leases at December 31, 2021 | $ | |||
| Lease liabilities - operating leases on adoption date and increase in lease liabilities | $ | |||
| Payments on lease liabilities | ( | ) | ||
| Lease liabilities - operating leases on December 31, 2021 | ||||
| Lease liabilities - operating leases due in the 12 months ending December 31, 2022 | ||||
| Lease liabilities - operating leases due after December 31, 2022 | $ |
Variable lease expense was $
Recent Developments
In fiscal 2021 and 2022 to date, management has expanded on the services and options the Company provides for its customers. A new website for the Extremit-Ease product was created and is operational (www.extremitease.com). Management is also working on new Business to Customer (B to C) channels to provide Retail customers better opportunity to purchase our products. The Company also expanded its facilities in January 2021, moving into approximately 18,000 square feet of office and warehouse space. This move brought the Company back under a single roof. This has already proven to be very beneficial to our operations. In fiscal 2020, AMERX’s Extremit-Ease Compression Garment line expanded with the introduction of a Tan version of the garment and matching liner.
Impact of COVID-19 on Our Business
The financial effects of the COVID-19 pandemic started showing their impact on our Company in March of 2020. Due to the timing of these events, the full effect of COVID-19 on our business cannot yet be fully quantified. We have felt the effects of the COVID-19 pandemic in our operations, as management continues to dedicate time and effort researching, discussing and implementing policies and procedures necessary to navigate through the ever changing landscape the COVID-19 pandemic has and continues to provide. As an essential business, management was tasked with remaining open, while keeping our employees safe, and providing our customers, who were still able to actively provide healthcare services, with the products they need.
Updating the effects of COVID-19 on our business, currently we have seen fluctuations in our market due to the latest Omicron variant of the COVID-19 virus. The virius’s presence has caused patients to continue to cancel appointments and the medical market to restrict access to elective surgeries. We continue to monitor operations, and are still implementing policies and procedures to keep all our employees as safe as possible. Management does not believe it will truly be able to assess the affects of COVID-19 at this time or in the future, with any certainty.
CRITICAL ACCOUNTING POLICIES AND ESTIMATES
The Company's condensed consolidated financial statements have been prepared in accordance with standards of the Public Company Accounting Oversight Board (United States), which require the Company to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and the related disclosures. A summary of those significant accounting policies can be found in the Notes to the Consolidated Financial Statements included in the Company's annual report on Form 10-K, for the year ended June 30, 2021, which was filed with the Securities and Exchange Commission on October 8, 2021, and as contained in the amendment of the Company's annual report on Form 10-K/A, as filed with the Securities and Exchange Commission on November 12, 2021, which contain certain restatements to the June 30, 2021 financial statements. The estimates used by management are based upon the Company's historical experiences combined with management's understanding of current facts and circumstances. Certain of the Company's accounting policies are considered critical as they are both important to the portrayal of the Company's financial condition and the results of its operations and require significant or complex judgments on the part of management. We believe that the following critical accounting policies affect the more significant judgments and estimates used in the preparation of our consolidated financial statements.
Accounts Receivable Allowance
Accounts receivable allowance reflects a reserve that reduces our customer accounts and receivable to the net amount estimated to be collectible. The valuation of accounts receivable is based upon the credit-worthiness of customers and third-party payers as well as historical collection experience. Allowances for doubtful accounts are recorded as a selling, general and administrative expense for estimated amounts expected to be uncollectible from third-party payers and customers. The Company bases its estimates on its historical collection experience, current trends, credit policy and on the analysis of accounts by aging category. At December 31, 2021, and June 30, 2021, our allowance for doubtful accounts totaled $4,925 and $9,408, respectively.
Advertising and Marketing
The Company uses several forms of advertising, including sponsorships to agencies who represent the professionals in their respective fields. The Company expenses these sponsorships over the term of the advertising arrangements on a straight line basis. Other forms of advertising used by the Company include professional journal advertisements, distributor catalogs, website and mailing campaigns. These forms of advertising are expensed when incurred.
Deferred Income Taxes
Deferred income taxes are recognized for the expected tax consequences in future years for differences between the tax bases of assets and liabilities and their financial reporting amounts, based upon enacted tax laws and statutory tax rates applicable to the periods in which the differences are expected to affect taxable income. The Company accounts for income taxes under Topic 740 - Income Tax in the Accounting Standards Codification. A valuation allowance is used to reduce deferred tax assets to the net amount expected to be recovered in future periods. The estimates for deferred tax assets and the corresponding valuation allowance require us to exercise complex judgments. We periodically review and adjust those estimates based upon the most current information available. The Company had a valuation allowance of $31,960 as of December 31, 2021 and $0 as of June 30, 2021, respectively. Because the recoverability of deferred tax assets is directly dependent upon future operating results, actual recoverability of deferred tax assets may differ materially from our estimates.
Revenue Recognition
The Company recognizes revenue in accordance with the Financial Accounting Standards Board's (FASB) release of Accounting Standards Update (ASU) 2014-09, Revenue from Contracts with Customers (Topic 606) which requires that five basic criteria must be met before revenue can be recognized: (1) identify the contract with a customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to the performance obligations in the contract, and (5) recognize revenue when (or as) the entity satisfies a performance obligation.
Stock Based Compensation
Stock based compensation is accounted for in accordance with Topic 718 - Compensation - Stock Compensation in the Accounting Standards Codification. All share-based payments to employees, including grants of employee stock options, are to be recognized in the statement of operations based upon their fair values. Topic 718 rescinds the acceptance of pro forma disclosure.
FINANCIAL CONDITION
As of December 31, 2021 the Company's principal sources of liquid assets included cash of $806,574, inventories of $1,035,515, and net accounts receivable of $418,591. The Company also has $280,840 in Certificate of Deposits. The Company had net working capital of $2,178,467, and long-term lease liability of $573,528, at December 31, 2021.
During the six months ended December 31, 2021 cash decreased from $1,226,522 as of June 30, 2021, to $806,574. Operating activities used cash of $291,633 during the period. Investing activities used cash of $52,208. Financing activities used cash of $76,107.
The Company reflected a net non-current deferred tax asset of $82,308, at December 31, 2021. Because the recoverability of deferred tax assets is directly dependent upon future operating results, actual recoverability of deferred tax assets may differ materially from our estimates.
RESULTS OF OPERATIONS
Comparison of the three and six months ended December 31, 2021 and 2020.
Net sales during the quarter ended December 31, 2021, were $1,330,636 as compared to the previous year's quarter net sales of $1,174,405, an increase of $156,231, or approximately 13%. We believe increased sales were driven by increases in our customer base, as well as current customers taking advantage of new program offerings. Net sales during the six months ended December 31, 2021, were $2,520,613 as compared to the previous year's period net sales of $2,420,648, an increase of $99,965, or approximately 4%. We believe increased sales were driven by increases in our customer base, as well as current customers taking advantage of new program offerings.
Gross profit during the quarter ended December 31, 2021, was $918,722 as compared to $845,834 during the quarter ended December 31, 2020, an increase of $72,888 or 9%. As a percentage of net sales, gross profit was approximately 69% in the quarter ended December 31, 2021, and approximately 72% in the corresponding quarter in 2020. The decrease in profit was a result, primarily related to a one time sale, at low margin. Gross profit during the six months ended December 31, 2021, was $1,780,446 as compared to $1,757,756 during the six months ended December 31, 2020, an increase of $22,690 or 1%. As a percentage of net sales, gross profit was approximately 71% in the six months ended December 31, 2021, and approximately 73% in the corresponding period in 2020.
Operating expenses during the quarter ended December 31, 2021 were $972,632, consisting of $497,261 in salaries and benefits and $475,371 in selling, general and administrative expenses. This compares to operating expenses during the quarter ended December 31, 2020 of $740,959, consisting of $414,467 in salaries and benefits; and $326,492 in selling, general and administrative expenses. Expenses for the quarter ended December 31, 2021, increased by $231,672 or approximately 31% compared to the corresponding quarter in 2020. Salaries and Benefits increased as a result of hiring additional sales support staff and warehouse support, as well as increased salaries driven by the current economies of the available workforce. Operating expenses increased primarily due to increases in marketing expenses, distribution fees associated with a new customer and rent expense from our new offices. Operating expenses during the six months ended December 31, 2021 were $1,768,472, consisting of $936,721 in salaries and benefits and $831,751 in selling, general and administrative expenses. This compares to operating expenses during the six months ended December 31, 2020 of $1,436,333, consisting of $826,721 in salaries and benefits; and $609,612 in selling, general and administrative expenses. Expenses for the six months ended December 31, 2021, increased by $332,139 or approximately 23% compared to the corresponding quarter in 2020. Salaries and Benefits increased as a result of hiring additional sales support staff and warehouse support, as well as increased salaries driven by the current economies of the available workforce. Operating expenses increased primarily due to increases in marketing expenses, distribution fees associated with a new customer, and rent expense from our new offices.
Operating profit decreased by $158,784 to an operating loss of $53,909 for the quarter ended December 31, 2021, as compared to an operating profit of $104,875 in the comparable quarter of the prior year. The decrease in net income for the three month period, of the comparable quarter of the prior year before income taxes was primarily attributable to the increase in marketing expenses and rent associated with our new offices. Operating profit decreased by $309,449 to an operating profit of $11,974 for the six months ended December 31, 2021, as compared to an operating profit of $321,423 in the comparable six months of the prior year. The decrease in net income for the six month period, of the comparable six month’s of the prior year before income taxes was primarily attributable to the increase in marketing expenses and rent associated with our new offices.
ITEM 4. CONTROLS AND PROCEDURES
| (a) |
Evaluation of Disclosure Controls and Procedures |
Management of the Company, with the participation of the Chief Executive Officer and Chief Financial Officer, has conducted an evaluation of the effectiveness of the Company's disclosure controls and procedures pursuant to Rule 13a-15 under the Securities Exchange Act of 1934 as of the end of the period covered by this report. Based on that evaluation, management, including the Chief Executive and Chief Financial Officer, has concluded that, as of the end of the period covered by this report, the Company's disclosure controls and procedures were not effective in ensuring that all material information relating to the Company required to be disclosed in this report has been made known to management in a timely manner and ensuring that this information is recorded, processed, summarized and reported within the time periods specified in the SEC's rules and regulations, because of the identification of a material weakness in our internal controls over financial reporting, identified below, which we view as an integral part of our disclosure controls and procedures.
| (b) |
Changes in Internal Controls Over Financial Reporting |
As previously reported, our annual assessment of the internal controls over financial reporting as of June 30, 2021 revealed a deficiency that we consider to be a material weakness: inadequate segregation of duties consistent with control objectives.
During fiscal 2022, the Company will continue to address changes needed to improve segregation of duties consistent with control objectives. We have added staff to grow sales. We expect that increased sales will enable us to add support staff, specifically in the accounting and shipping departments. A secondary effect of adding more staff will address needed improvements in segregation of duties consistent with control objectives.
PART II. OTHER INFORMATION
ITEM 5. OTHER INFORMATION
ITEM 6. EXHIBITS
| (A) |
EXHIBITS |
| // | 10.1 |
| // | 10.2 | |
| // | 10.3 | Restated and Amended Executive Employment Agreement effective July1, 2021 between George O. Borak, Procyon Corporation and AMERX Health Care Corporation. |
| ++ | 10.5 | Business Line of Credit - Loan Agreement dated June 10, 2021 |
| ++ | 10.6 | Business Line of Credit - Promissory Note dated June 10, 2021 |
| ** | 10.7 | Lease, effective January 15, 2021. |
| ** | 10.8 | Lease, effective January 15, 2021. |
| 31.1 | Certification of Justice W. Anderson pursuant to Exchange Act Rule 13a-14(a)/15d-14(a) | |
| 31.2 | Certification of James B. Anderson pursuant to Exchange Act Rule 13a-14(a)/15d-14(a) | |
| 32.1 | Certification Pursuant to 18 U.S.C.§1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act Of 2002 | |
| 101.1* | The following materials from the Company's Quarterly Report on Form 10-Q for the quarter ended December 31, 2021, formatted in iXBRL (Inline Extensible Business Reporting Language): (I) the Condensed Balance Sheets, (ii) the Condensed Consolidated Statements of Operations, (iii) the Consolidated Statements of Cash Flows, and (iv) the Notes to Condensed Consolidated Financial Statements | |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL and contained in Exhibit 101) | |
| * | Furnished, not filed | |
| // | Incorporated by reference to the Company’s form 8-K filed on or about July 28, 2021. | |
| ++ | Incorporated by reference to the Company’s form 10-K filed on or about October 28, 2021. | |
| ** | Incorporated by reference to the Company’s form 8-K filed on or about February 28, 2021. |
SIGNATURES
In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, there unto duly authorized.
|
|
PROCYON CORPORATION |
|
|
| February 14, 2022 |
By: |
/s/ JUSTICE W. ANDERSON |
|
| Date |
|
Justice W. Anderson, Chief Executive Officer |
|
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Evergy Schedules Conference Call to Discuss 1st Quarter Results
- Grifols 2023 Annual Report on Form 20-F filed with the SEC
- Vesta Announces the Filing of Its Annual Report on Form 20-F for Fiscal Year 2023
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
